Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Towards Precision in HF Pharmacotherapy.

Current heart failure reports - 1 Feb 2017

Norgard Nicholas B, Hempel Carolyn

Abstract excerpt

PURPOSE OF REVIEW: Heart failure (HF) is a disease state with great heterogeneity, which complicates the therapeutic process. Identifying more precise HF phenotypes will allow for the development of more targeted therapies and improvement in patient outcomes. This review explores the future for precision medicine in HF treatment. RECENT FINDINGS: Rather than a continuous disease spectrum with a uniform...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Forecasting
Share to Heart Failure
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Share to Proteomics

Source

Identifiers

PMID: 28190189
DOI: 10.1007/s11897-017-0314-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Towards Precision in HF Pharmacotherapy.PMID 28190189Read ↗

Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview.Semantic proximity Read ↗

Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart AssociationSemantic proximity Read ↗

Drug Discovery and Development for Heart Failure Using Multi-Omics ApproachesSemantic proximity Read ↗

The emerging role of pharmacogenomics in the treatment of patients with heart failure.Semantic proximity Read ↗

Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized MedicineSemantic proximity Read ↗

Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives.Semantic proximity Read ↗

Omics phenotyping in heart failure: the next frontierSemantic proximity Read ↗

Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction.Semantic proximity Read ↗

Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension.Semantic proximity Read ↗

The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics.Semantic proximity Read ↗

Heart failure pharmacogenetics: past, present, and future.Semantic proximity Read ↗

Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.